Ovarian cancer: immunotherapy, quo vadis?

被引：0
作者：
Marme, Frederik [1 ,2 ]
机构：
[1] Heidelberg Univ, Konservat Gynakol Onkol, Med Fak Mannheim, Expt & Translat Gynakol Onkol, Heidelberg, Germany
[2] Univ Klinikum Mannheim, Frauenklin, Haus 1,Ebene 1,Theodor Kutzer Ufer 1-3, Mannheim, Germany
来源：
GYNAKOLOGIE | 2022年 / 55卷 / 08期
关键词：
REGULATORY T-CELLS; LYMPHOCYTE-ASSOCIATED ANTIGEN-4; PHASE-II; PLATINUM-RESISTANT; ANTITUMOR-ACTIVITY; ANTIBODY BLOCKADE; PD-L1; EXPRESSION; PATIENTS PTS; TUMOR; BEVACIZUMAB;
D O I：
10.1007/s00129-022-04963-0
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
引用
收藏
页码：591 / 602
页数：12
相关论文
共 74 条
[21]   Safety and Antitumor Activity of Anti-PD-1 Antibody, Nivolumab, in Patients With Platinum-Resistant Ovarian Cancer [J].
Hamanishi, Junzo ;
Mandai, Masaki ;
Ikeda, Takafumi ;
Minami, Manabu ;
Kawaguchi, Atsushi ;
Murayama, Toshinori ;
Kanai, Masashi ;
Mori, Yukiko ;
Matsumoto, Shigemi ;
Chikuma, Shunsuke ;
Matsumura, Noriomi ;
Abiko, Kaoru ;
Baba, Tsukasa ;
Yamaguchi, Ken ;
Ueda, Akihiko ;
Hosoe, Yuko ;
Morita, Satoshi ;
Yokode, Masayuki ;
Shimizu, Akira ;
Honjo, Tasuku ;
Konishi, Ikuo .
JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (34) :4015-+
[22]   Atezolizumab in combination with bevacizumab and chemotherapy versus bevacizumab and chemotherapy in recurrent ovarian cancer - a randomized phase III trial (AGO-OVAR 2.29/ENGOT-ov34) [J].
Harter, Philipp ;
Pautier, Patricia ;
Van Nieuwenhuysen, Els ;
Reuss, Alexander ;
Redondo, Andres ;
Lindemann, Kristina ;
Kurzeder, Christian ;
Petru, Edgar ;
Heitz, Florian ;
Sehouli, Jalid ;
Degregorio, Nikolaus ;
Wimberger, Pauline ;
Burges, Alexander ;
Cron, Nadin ;
Ledermann, Jonathan ;
Lorusso, Domenica ;
Paoletti, Xavier ;
Marme, Frederik .
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2020, 30 (12) :1997-2001
[23]   Prevalence of deleterious germline variants in risk genes including BRCA1/2 in consecutive ovarian cancer patients (AGO-TR-1) [J].
Harter, Philipp ;
Hauke, Jan ;
Heitz, Florian ;
Reuss, Alexander ;
Kommoss, Stefan ;
Marme, Frederik ;
Heimbach, Andre ;
Prieske, Katharina ;
Richters, Lisa ;
Burges, Alexander ;
Neidhardt, Guido ;
de Gregorio, Nikolaus ;
El-Balat, Ahmed ;
Hilpert, Felix ;
Meier, Werner ;
Kimmig, Rainer ;
Kast, Karin ;
Sehouli, Jalid ;
Baumann, Klaus ;
Jackisch, Christian ;
Park-Simon, Tjoung-Won ;
Hanker, Lars ;
Kroeber, Sandra ;
Pfisterer, Jacobus ;
Gevensleben, Heidrun ;
Schnelzer, Andreas ;
Dietrich, Dimo ;
Neunhoeffer, Tanja ;
Krockenberger, Mathias ;
Brucker, Sara Y. ;
Nuernberg, Peter ;
Thiele, Holger ;
Altmueller, Janine ;
Lamla, Josefin ;
Elser, Gabriele ;
du Bois, Andreas ;
Hahnen, Eric ;
Schmutzler, Rita .
PLOS ONE, 2017, 12 (10)
[24]   Deleterious somatic variants in 473 consecutive individuals with ovarian cancer: results of the observational AGO-TR1 study (NCT02222883) [J].
Hauke, Jan ;
Hahnen, Eric ;
Schneider, Stephanie ;
Reuss, Alexander ;
Richters, Lisa ;
Kommoss, Stefan ;
Heimbach, Andre ;
Marme, Frederik ;
Schmidt, Sandra ;
Prieske, Katharina ;
Gevensleben, Heidrun ;
Burges, Alexander ;
Borde, Julika ;
De Gregorio, Nikolaus ;
Nuernberg, Peter ;
El-Balat, Ahmed ;
Thiele, Holger ;
Hilpert, Felix ;
Altmueller, Janine ;
Meier, Werner ;
Dietrich, Dimo ;
Kimmig, Rainer ;
Schoemig-Markiefka, Birgid ;
Kast, Karin ;
Braicu, Elena ;
Baumann, Klaus ;
Jackisch, Christian ;
Park-Simon, Tjoung-Won ;
Ernst, Corinna ;
Hanker, Lars ;
Pfisterer, Jacobus ;
Schnelzer, Andreas ;
du Bois, Andreas ;
Schmutzler, Rita K. ;
Harter, Philipp .
JOURNAL OF MEDICAL GENETICS, 2019, 56 (09) :574-580
[25]  
Hinchcliff E, 2021, GYNECOL ONCOL, V162, pS39
[26]   Immunologic and clinical effects of antibody blockade of cytotoxic T lymphocyte-associated antigen 4 in previously vaccinated cancer patients [J].
Hodi, F. Stephen ;
Butler, Marcus ;
Oble, Darryl A. ;
Seiden, Michael V. ;
Haluska, Frank G. ;
Kruse, Andrea ;
MacRae, Suzanne ;
Nelson, Marybeth ;
Canning, Christine ;
Lowy, Israel ;
Korman, Alan ;
Lautz, David ;
Russell, Sara ;
Jaklitsch, Michael T. ;
Ramaiya, Nikhil ;
Chen, Teresa C. ;
Neuberg, Donna ;
Allison, James P. ;
Mihm, Martin C. ;
Dranoff, Glenn .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2008, 105 (08) :3005-3010
[27]   Biologic activity of cytotoxic T lymphocyte-associated antigen 4 antibody blockade in previously vaccinated metastatic melanoma and ovarian carcinoma patients [J].
Hodi, FS ;
Mihm, MC ;
Soiffer, RJ ;
Haluska, FG ;
Butler, M ;
Seiden, MV ;
Davis, T ;
Henry-Spires, R ;
MacRae, S ;
Willman, A ;
Padera, R ;
Jaklitsch, MT ;
Shankar, S ;
Chen, TC ;
Korman, A ;
Allison, JP ;
Dranoff, G .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (08) :4712-4717
[28]   The PARP1 inhibitor BMN 673 exhibits immunoregulatory effects in a Brca1-/- murine model of ovarian cancer [J].
Huang, Jing ;
Wang, Lei ;
Cong, Zhongyi ;
Amoozgar, Zohreh ;
Kiner, Evgeny ;
Xing, Deyin ;
Orsulic, Sandra ;
Matulonis, Ursula ;
Goldberg, Michael S. .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2015, 463 (04) :551-556
[29]   Prognostic significance of tumor-infiltrating T cells in ovarian cancer: A meta-analysis [J].
Hwang, Wei-Ting ;
Adams, Sarah F. ;
Tahirovic, Emin ;
Hagemann, Ian S. ;
Coukos, George .
GYNECOLOGIC ONCOLOGY, 2012, 124 (02) :192-198
[30]   PARP Inhibitor Upregulates PD-L1 Expression and Enhances Cancer-Associated Immunosuppression [J].
Jiao, Shiping ;
Xia, Weiya ;
Yamaguchi, Hirohito ;
Wei, Yongkun ;
Chen, Mei-Kuang ;
Hsu, Jung-Mao ;
Hsu, Jennifer L. ;
Yu, Wen-Hsuan ;
Du, Yi ;
Lee, Heng-Huan ;
Li, Chia-Wei ;
Chou, Chao-Kai ;
Lim, Seung-Oe ;
Chang, Shih-Shin ;
Litton, Jennifer ;
Arun, Banu ;
Hortobagyi, Gabriel N. ;
Hung, Mien-Chie .
CLINICAL CANCER RESEARCH, 2017, 23 (14) :3711-3720
12345678